Top news of the week: 06.09.2022.
Mayflower BioVentures to Announce New Cell & Gene Therapy Companies within Months
A cell and gene therapy accelerator formed by Mayo Clinic, Hibiscus BioVentures and Innoforce is officially up and running, the partners announced this week.
Mayo Clinic Joins With Industry Groups to Launch Biotech Accelerator
The Mayflower BioVentures accelerator will start cell- and gene-therapy companies.
Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight
In the last five years, Mubadala Capital Ventures has gone from a name that few people in the biotech world recognized to a firm that’s earned the respect of top-tier biotech investors and ...
The 21 most promising healthtech startups of 2022, according to top VCs
We asked top venture capitalists to name the most promising US healthtech startups so far in 2022, from digital pharmacies to health-data hubs.
InnovationRx: FDA Greenlights Omicron Boosters; Plus: Biotech’s Cash Cushion
InnovationRx is your weekly digest of healthcare news. Sign up!
Reauthorization of SBIR/STTR Program Funding Webinar
With the recent news around the pending renewal of SBIR/STTR programs, BIO will be co-hosting a unique webinar with the Council of State Biosciences Associations (CSBA) AdvaMed’s Accel ...
Drugging RNA with pills: small molecules for a big frontier
A handful of startups have formed in recent years with plans to target RNA with small molecules. Many have caught the attention of big drugmakers.
Novartis’ Bradner steps down as research head amid company shake-up
A well-known physician-scientist who joined Novartis from Harvard, Jay Bradner spent over six years steering the company’s research hub. He will be replaced by Merck executive Fiona ...